Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Washington for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Washington only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Washington (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Joseph Ye (NPI 1700881422)

Field	Value
Entity Type	Individual
Organization	Joseph Ye
Address	420 Mcphee Rd Sw
City	Olympia
State	WA
ZIP	98502
Taxonomy	Medical Oncology Physician
NPI Enumerated	June 17, 2005

Payer Source	Total Paid
Medicare	$2.5M
Medicaid	$0

Key Findings

Provider profile and tenure: JOSEPH YE is a Medical Oncology Physician based in OLYMPIA, WA with an NPI enumerated on 2005-06-17 (~21 years ago), indicating a long-established Medicare billing history in the market. The taxonomy and code mix align with an outpatient oncology infusion practice rather than a procedure-only specialty.

Payer mix and scale: This provider’s lifetime Medicare revenue is $2.5M and there is no Medicaid billing on file (none), so the practice is effectively single-payer from a public-program perspective with material exposure concentrated in Medicare. Analysts should treat Medicare as the primary public reimbursement stream for network and access assessments.

Revenue concentration in Medicare: The top three Medicare codes account for 69.2% of the provider’s total Medicare revenue, driven by J9271 ($799.8K, 33.1%), J9299 ($564.5K, 23.3%), and J0897 ($308.9K, 12.8%). This high concentration means most revenue is tied to a small set of oncology drug administrations.

Service-line implications: The dominant codes (J9271, J9299, J0897) are high-cost injectable oncology agents, supported by chemotherapy administration codes such as 96413 and infusion add-ons like 96417 and 96365. The mix (including supportive agents Q5119, Q5122, J1442) indicates an infusion-centered oncology practice that manages systemic cancer therapy and associated supportive care onsite.

Competitive standing by code: For immunotherapy, J9271 ranks #479 of 1841 providers (74th percentile) and J9299 ranks #120 of 505 providers (76th percentile), both described as typical, unremarkable national volumes; by contrast J0897 ranks #450 of 10057 providers (96th percentile) and is noted as notably above typical national volume, signaling relatively stronger market share for that agent. These ranks suggest a modest-to-strong national presence depending on the drug, with particular prominence in denosumab billing.

Statistical outliers and intensity of clinical services: Certain non-drug codes are flagged as extreme or notably above typical volumes — 99214 is listed as an "extreme outlier, far above typical national volume" (1.8K claims, $168.3K, 7.0%), and 96417 is an "extreme outlier, far above typical national volume" (348 claims, $17.7K, 0.7%). Additionally, M0010 (EOM enhanced services) ranks #11 of 544 (98th percentile; notably above typical national volume), which together indicate above-average billing for higher-intensity office management and infusion add-on services.

Operational and contracting implications: The practice’s revenue model is drug-and-infusion centric (top drugs comprise the majority of revenue), creating both negotiating leverage around high-cost oncology agents and concentration risk if utilization shifts or reimbursement changes for J9271/J9299/J0897. Payers and network managers should prioritize drug reimbursement terms and utilization management for these codes when evaluating contracting or prior authorization strategies.

Ancillary billing pattern and supply utilization: The dataset includes very high claim counts with low per-claim payments for several ancillary agents (for example J1442: 11.9K claims, $11.9K revenue; J0185: 10K claims, $10K revenue), indicating routine dispensing/administration of low-unit-cost supportive medications at scale. These high-count, low-dollar items can drive operational billing volume and reconciliation work even though they contribute modestly to total revenue.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

70 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	18,600	$40	$799.8K
J9299	Injection, nivolumab, 1 mg	23,520	$20	$564.5K
J0897	Injection, denosumab, 1 mg	16,260	$20	$308.9K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,770	$100	$168.3K
J9264	Injection, paclitaxel protein-bound particles, 1 mg	9,710	$10	$97.1K
Q5119	Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg	3,790	$20	$83.3K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	720	$100	$73.6K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	280	$140	$38.1K
J1437	Injection, ferric derisomaltose, 10 mg	1,900	$20	$30.4K
Q5122	Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg	340	$80	$28.2K

Showing 1–10 of 70

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 70 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Washington Distribution

Joseph Ye — 15 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Washington

Full comparison — all codes billed, vs. state median

70 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	2	30	9,600	$40	$465.7K
J9299	2	10	17,740	$20	$404.3K
J9264	2	10	18,210	$10	$177.5K
J0897	2	150	1,800	$20	$57.9K
J3490	22	70	70	$50	$51.2K
Q5119	1	10	1,460	$20	$43.9K
Q5122	2	10	340	$100	$34.8K
J0885	5	10	4,800	$10	$28.9K
J1437	1	10	1,600	$20	$26.4K
96413	3	160	80	$110	$15K

Showing 1–10 of 70

Related Providers

Other providers that share a Tax Identification Number (TIN) with Joseph Ye, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Columbus Radiology Corp	OH	Diagnostic Radiology Physician	$0	$49.9M
Wilfredo Blasini	FL	Clinical Pathology Physician	$16.9M	$307.9K
Ryan Olson	FL	Anatomic Pathology & Clinical Pathology Physician	$12.8M	$80
American Oncology Partners PA	OH	Hematology & Oncology Physician	$0	$11.8M
Robert Mcdonald	AZ	Diagnostic Radiology Physician	$7.5M	$0
David Smith	MD	Hematology & Oncology Physician	$6.4M	$0
Stephen Divers	AR	Hematology & Oncology Physician	$3.9M	$1.5K
Robert Muldoon	AR	Hematology & Oncology Physician	$3.2M	$0
Bradley Sumrall	GA	Medical Oncology Physician	$3.1M	$0
Linda Hendricks	GA	Specialist	$3.1M	$0

Nearby Providers

Other providers in the same ZIP code as Joseph Ye, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Multicare Health System	WA	General Acute Care Hospital	$0	$17M
Northwest Resources Ii	WA	Addiction (Substance Use Disorder) Counselor	$0	$15.4M
Capital Anesthesia, LLC	WA	Certified Registered Nurse Anesthetist	$0	$15.2M
Olympia Orthopaedic Associates PLLC	WA	Ambulatory Surgical Clinic/Center	$6M	$6.8M
Pathways Mental Health Services	WA	Mental Health Counselor	$0	$3.1M
Susanne Carmack	WA	Anatomic Pathology & Clinical Pathology Physician	$1.8M	$0
Linli Xuan	WA	Hematology & Oncology Physician	$1M	$0
Olympia Multi-specialty Clinic Ambulatory Procedures Cntr PLLC	WA	Ambulatory Surgical Clinic/Center	$917.6K	$90.6K
Ryan Halpin	WA	Neurological Surgery Physician	$756.1K	$0
Min Kang	WA	Hematology & Oncology Physician	$687.5K	$0

Joseph Ye — Billing Profile & Reimbursement Data

Sign up for Joseph Ye — Billing Profile & Reimbursement Data policy alerts

Joseph Ye — Billing Profile & Reimbursement Data

Sign up for Joseph Ye — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References